¿El agregado de un fármaco antipsicótico de segunda mejorar el tratamiento de clozapina?

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2010
Cargando información sobre las referencias

CRD SUMMARY:

This review concluded that the evidence base for adding a second antipsychotic to clozapine, in partially responsive patients with schizophrenia, was weak and that the benefit was at best modest. The authors' conclusions seem reasonable and are likely to be reliable.
Epistemonikos ID: efd29f2a2622083fd77a6736f4c3f7275e3eb933
First added on: Jun 06, 2012